The Antibody Society has partnered with numerous conference organizers, including Informa Connect, Cambridge Healthtech Institute, Hanson Wade, and Terrapinn, to ensure our members receive substantial discounts on meeting registration fees. As a courtesy, we also list meetings held by non-profit organizations, such as Gordon Research Conferences and KeyStone Symposia.
To access the discount codes, please log into website and navigate to the Member discount codes page in the Members Only area.
The Antibody Society members save 20% off your booking – log into the Members Only area or contact membership@antibodysociety.org for the discount code.
Schrödinger’s online course, Introduction to Computational Antibody Engineering, will show how industry-leading computational molecular modeling solutions are used to aid in antibody discovery and design and how to incorporate these computational approaches into your research project. This course will also provide a chance to work hands-on with Schrödinger’s BioLuminate software.
We are pleased to offer 20% discounts to our members for their online course, Introduction to Computational Antibody Engineering.
January 2025
PepTalk: The Protein Science and Production Week
January 13-16, 2025 | San Diego, CA | CHI-PepTalk.com
PepTalk: The Protein Science and Production Week is the premier conference dedicated to advancing biotherapeutic discovery and development. With over two decades of experience, PepTalk provides comprehensive programming and innovative solutions that bridge biotherapeutic research and practical application. Throughout the week, precise and dedicated pipelines offer symposia, conference tracks, and training seminars focused on protein expression, production platforms, lab automation for higher throughput, analytical methods including developability and characterization, antibody discovery and development, and new this year, targeted therapies and drug delivery systems. Learn from expert speakers, engage with a devoted community, and gain valuable tools to propel your research forward.
Experience four days of immersive learning, world-class presentations, poster sessions, keynotes, roundtable sessions, panel discussions, exhibitions, and unparalleled networking opportunities.
The Antibody Society members save 10% off the conference registration – contact membership@antibodysociety.org or visit the Members Only section of the website to find the discount code.
February 2025
Collaborate with industry leaders from Bristol Myers Squibb, Xencor, AbbVie, Johnson & Johnson, and more at the Antibody Therapeutics San Diego Roundtable Xchange, taking place on 19th February 2025 at the Handlery Hotel, San Diego.
This exclusive roundtable-format event is designed only for senior antibody-focused decision-makers from Pharma and Biotech. Engage in dynamic discussions on cutting-edge topics: Antibody Drug Conjugates | Lead Identification & Optimization | Formats & Scaffolds | Bi/Multi-specifics.
Roundtable facilitators include;
- Christopher Roth, Vice President of Research, Abilita Therapeutics
- Jacob Gano, Head of Antibody Engineering, Protillion Biosciences
- Bishnu Nayak, Senior Director & Site Head, NeologicsBio
- Max Cherf, Director, Mammalian Display, Tentarix Biotherapeutics
- Anindya Bagchi, Co-founder, Styx Biotechnologies
- Alex Sevy, Director of Antibody Therapeutics, Aegis Life
- Alon Wellner, VP of Biology, Aureka Bio
hubXchange’s Roundtable Series transforms the traditional industry event experience by creating a uniquely intimate and senior-level platform for meaningful collaboration and innovation.
- Focused Discussions: Engage in targeted roundtable conversations with C-level executives and senior scientists, addressing critical challenges in Antibody Therapeutics, Immunotherapies, AI in Drug Discovery, and Advanced Therapies.
- Expertly Curated Programs: Our one-day events are designed for busy professionals, offering actionable insights and maximizing efficiency.
- Personalized Agendas: Each attendee receives a custom agenda tailored to their specific goals and priorities, ensuring a truly impactful experience.
- Strategic 1:1 Meetings: Pre-scheduled meetings with hand-selected service providers foster meaningful partnerships and productive dialogues.
- Exclusive Networking: Connect with a pre-qualified group of senior professionals, guaranteeing high-level discussions and collaboration.
At hubXchange, we focus on fostering lasting connections and solution-driven dialogue to help drive innovation forward in the life sciences and biotech industries.
Register Today!
Secure your complimentary pass now: Reserve your spot
March 2025
NextGen BioMed 2025
Join us in London from March 12-14 at NextGen Biomed 2025 to explore the latest in biomedical research with programmes tailored to your interests.
Discover advancements in antibody discovery, transformative immunotherapy for cancer and other diseases, and the future of vaccines R&D.
Enjoy 9 content tracks, thought leadership discussions, fireside chats, workshops, and a vibrant start-up zone to form valuable connections and progress your research. We look forward to welcoming you!
Register today and explore full event details here!
May 2025
Sydney Antibody Therapeutics Conference 2025 | 7th & 8th May, 2025
Join leading experts from academia and industry at the Sydney Antibody Therapeutics Conference 2025, a premier event showcasing the latest innovations in antibody drug discovery and development. This two-day conference will feature research, networking opportunities, and discussions on emerging therapeutic strategies.
Keynote Speakers
Sally Ward – Former President of The Antibody Society, Professor of Molecular Immunology, University of Southampton
Sir Greg Winter – 2018 Nobel Laureate, Trinity College, Cambridge University
Juliet Gerrard – Professor of Biochemistry, University of Auckland
Learn more & register: Sydney Antibody Therapeutics Conference
Unlock the future of Biologics & Protein Engineering with BioGlyph Luma. | Thursday, May 8, 2025 (5-7pm) | Foundry & Lux, South San Francisco.
We’re bringing together leading minds in biopharma to explore next-generation biologics workflows and to unveil BioGlyph Luma, our new solution designed to streamline antibody and protein engineering. The event will feature expert presentations, a live Q&A, and a keynote from William Shirley, Executive Director of Research Informatics at Gilead Sciences, who will share insights on building a scalable biological informatics ecosystem.
Register now and explore the full event details here!
PEGS: The Essential Protein & Antibody Engineering Summit
May 12-16, 2025 | Boston, MA
The PEGS Boston Summit is the premier event for biologics and protein engineering. Bringing together a global community of experts, innovators, and leaders in the field, the Summit offers cutting-edge insights into the latest advances in drug development, protein and antibody engineering, immunotherapy, radiotherapy, and AI/ML-driven biologics research. With over 300 presentations, breakout sessions, and interactive seminars, attendees will have unparalleled opportunities to network, learn, and engage in meaningful collaborations. The exhibit hall features top product and service providers, creating a gathering space for discovery, innovation, and fun.
Join us at the PEGS Boston Summit to be part of the next wave of breakthroughs shaping the future of biologics.
Learn more
TAbS members save 10% off the conference registration.
Contact membership@antibodysociety.org or visit the ‘Members Only’ section on the TAbS website to find the discount code.
Learn about the cutting-edge advancements in humanized mice for predicting the clinical safety, efficacy, and pharmacokinetics of biologics and connect with key opinion leaders in the field.
Antibodies and complement : B cells, antibodies, complement functions & therapeutics: May 26-30, 2025 | Catania, Sicily, ITALY.
The antibody response and the complement system are major effector arms of the immune system. They contribute to destruction of infectious invaders and unhealthy cells. Upon Fab binding, the antibody’s Fc region induces target cell clearance by recruiting proteins of the human complement system, which trigger a sequence of reactions that results in effective phagocytosis and direct target cell lysis. Next to their beneficial role in host defenses, antibodies and complement are also involved in a plethora of pathological conditions, including autoimmunity, allergy, infections and cancer.
As the portfolio of antibody—and complement-effector function grow, high-end technological solutions are developed and novel therapeutic applications are proposed.
This 4th conference on Antibodies & Complement will focus attention on key advances in both fields with the aim at fostering discussions between antibody experts and complement experts. This edition will expand to antibody-producing cell (B & plasma cell) generation and vaccine development.This is the only meeting combining antibody and complement research.Some of the critical topics to be covered include:
- Germinal Centers, B Cell And Antibody Development
- Complement Mediated Responses And Drugs
- Antibody Induced Complement Activity
- Novel Therapeutics In The Clinic
- Vaccines & Delivery Systems
View the full program, agenda, and speaker list!
June 2025
Antibody Engineering & Therapeutics Europe 10 – 12 June, 2025 | Congress Center, Basel Switzerland
The Antibody Engineering & Therapeutics Europe conference is where cutting-edge science meets collaboration. As a premier forum for antibody engineering, therapeutics, and immunobiology, this event has brought together world-class academic and industry scientists for over 25 years to accelerate research, discovery, and clinical advancements.
This year, we’re excited to welcome you to Basel, Switzerland, a thriving biotech hub and the perfect setting for groundbreaking discussions, networking, and innovation.
Guided by the expertise of The Antibody Society, whose members serve as Scientific Advisors and Session Chairs, the conference provides unparalleled opportunities for knowledge exchange and collaboration.
Join us to explore breakthrough topics, including Fc Engineering, Novel Approaches to Antibody Discovery, Multispecific Antibodies, Agonists, Conditionally Active Biotherapeutics, ADCs, Degraders, Theranostics, and much more.
Exclusive Offer: Antibody Society members enjoy 15% – Reach out to info@antibodysociety.org to claim.
Academics, take advantage of our special offer, bring a colleague for free! When you register, you’ll receive a complimentary pass for a fellow academic, doubling the opportunities for collaboration and learning, speak to Felicity.Bell@Informa.com to find out more.
We’re pleased to share a series of upcoming life science roundtable events that may be of interest to members working in immunotherapies, antibody engineering, advanced therapies, AI in drug discovery, and related fields.
hubXchange returns with its Boston Life Science Xchange Series, a set of highly focused, one-day events designed to foster peer-to-peer engagement among senior-level scientists and industry leaders. These meetings combine curated roundtable discussions, expert-led presentations, pre-arranged 1:1 meetings, and poster sessions—all in a format that encourages meaningful dialogue and actionable insights.
Event Schedule:
-
Immunotherapies Xchange – June 17, 2025
-
Antibody Drug Conjugates Therapeutics Xchange – June 18, 2025
-
Antibody Therapeutics Xchange – June 23, 2025
-
Advanced Therapies Xchange – June 24, 2025
-
AI in Drug Discovery Xchange – June 25, 2025
-
Oligonucleotide Therapeutics Xchange – June 26, 2025
hubXchange’s unique approach emphasizes collaboration and curated matchmaking over traditional lectures, creating a high-value platform for addressing sector-specific challenges in a time-efficient setting.
There is no registration fee for qualified participants, and the one-day format is designed to minimize disruption to your lab or office schedule.
To learn more or express interest in participating, visit www.hubxchange.com or contact us at membership@antibodysociety.org.
Members of The Antibody Society will be given free passes upon registration.
Click to register for the Antibody Therapeutics Xchange – June 23, 2025
Click to register for the Antibody Drug Conjugates Therapeutics Xchange – June 18, 2025
7th T-Cell Engager Therapeutics Summit: Advancing Next-Generation Immune Therapies | June 24-26, 2025 | Boston, MA
Over the past two years, we have witnessed a huge rise in the T-Cell Engager field, with eight new approvals! The recent approval of tarlatamab in solid tumors, combined with the surge in business development, has helped reinforce the belief that TCEs can become the dominant force in the immune-oncology and autoimmune space.
At this crucial point, the 7th T Cell Engager Therapeutics Summit returns, committed to accelerating safer and more effective TCEs to approval. As the only event exclusively focused on translating TCEs and immune cell engagers through the clinic, join 100+ immune engager trailblazers to explore innovations beyond CD3-based approaches, the integration of multispecific formats, and refined affinity tuning to enhance selectivity.
Join us to gain insights into:
- Expanding Applications: Explore the potential of HLA-directed engagers for enhanced tumor penetration, the use of MAIT cells to improve safety, and new targets for autoimmune diseases with Clasp, Biomunex, and Cullinan Therapeutics
- Clinical Advancements: Gain insights into tarlatamab’s approval, combination strategies, and resistance mechanisms with Amgen, plus a deep dive into costimulation approaches to tackle T-cell exhaustion with Rondo Therapeutics and Merck
- Translational Insights: Compare TCE designs for autoimmune and oncology indications with AstraZeneca and EpimAb to uncover emerging clinical breakthroughs and therapeutic opportunities
Join biotech leaders, pharma experts, and C-suite executives to stay ahead of the latest innovations shaping the future of T-cell engagers.
View the full program, agenda, and speaker list!
The Antibody Society members save 10% off the conference registration.
Contact membership@antibodysociety.org or visit the ‘Members Only’ section on the TAbS website to find the discount code.
September 2025
Next Antibody Technologies and Therapeutics Conference in Prato, Italy, September 2025
The 3rd Antibody Technologies and Therapeutics Conference will be held at Monash University, Via Pugliesi 26, 59100 Prato, Italy on Sunday 11th to Wednesday 14th September 2022.
16th World Bispecific Summit | September 9-11, 2025 | Boston, MA
The 16th World Bispecific Summit is the leading industry-focused meeting dedicated to accelerating the development of next-generation bispecific and multispecific therapeutics. Bringing together global drug developers, pioneering biotechs, and the world’s top bispecific experts, the Summit delivers cutting-edge science and translational insight across discovery, engineering, preclinical development, and clinical advancement. Learn more in the full event guide here: https://ter.li/4qqet8
This year’s agenda directly reflects the hottest industry momentum including the intensifying PD-1/VEGF bispecific race, with major biopharma players like Pfizer, BMS, and Sanofi investing billions into dual-targeting innovation. Attendees will gain exclusive insights into structurally and functionally differentiated PD-1/VEGF candidates, including Ottimo Pharma’s OTP-01, and learn how leaders are optimizing therapeutic potential in this rapidly evolving space.
With 3 days of focused content, expert-led panels, and deep-dive case studies, attendees will explore new frontiers in tumour targeting, immune cell engagement, novel antibody formats, and combination strategies. From early R&D to clinical stage breakthroughs, the agenda is designed to solve the most pressing scientific and strategic challenges in the bispecific landscape.
The Summit also features a curated exhibition of top technology and service providers, creating a vibrant environment for innovation, networking, and meaningful partnership building.
Join us at the 16th World Bispecific Summit to be part of the next wave of bispecific innovation shaping the future of oncology.
The Antibody Society members save 10% off the conference registration. Contact membership@antibodysociety.org or visit the ‘Members Only’ section on the TAbS website to find the discount code.
October 2025
CDD for Biologics Summit | October 14 – 16, 2025
Are you looking for strategies to accelerate biologics design with AI, ML, and computational tools?
Look no further! This year’s 10th anniversary edition, in Boston, MA this October 14-16, features brand-new content, strategic insights and real-world case studies on protein design, computational, machine learning, in silico, and data science experts to advance CDD for biologics.
Bringing together 50+ industry pioneers across pharma and biotech companies, including GlaxoSmithKline, AstraZeneca, Amgen, AbbVie, Lilly, Novartis, and more to benchmark computational models, empower novel target discovery and advance biologics discovery. With the FDA’s recent announcement to phase out animal testing and the shift toward AI-based computational models, a new window of opportunity is opening for leaders in the computational drug development field to validate and scale these evolving approaches. This is your chance to join fellow CDD peers at the industry’s go-to forum to showcase pipeline developments driving faster, smarter, and more scalable therapeutic design, aligning with the forefront of innovation.
Explore the full 2025 agenda here
The Antibody Society members save 10% off the conference registration. Contact membership@antibodysociety.org or visit the ‘Members Only’ section on the TAbS website to find the discount code.
November 2025
16th Annual World ADC, San Diego 2025 – November 3-6, 2025
Touted as the world’s definitive, pre-eminent ADC forum to advance ADCs towards standard of care therapies, the 16th World ADC San Diego will return this November. Featuring over 170 speakers across 7 scientific end-to-end content streams, get your first look at the complete agenda here.
In an ever-growing landscape, where many are converging around validated payload MoAs and targets, this year’s content has been curated to highlight differentiation across the entire ADC value chain to ensure these therapies continue to provide meaningful impact to patients.
Highlights Include:
- Advancing Beyond Copycat Conjugates: Gain fresh insights into novel cytotoxic and non-cytotoxic payload mechanisms, emerging dual payload performance, and improved ADC tumor targeting to combat patient resistance with AstraZeneca, Byondis, and Genentech
- Overcoming the ADC Translational Mismatch: Explore detailed case studies on designing ADCs with better tolerability, learn best practices to predict clinical activity, and understand methods to mitigate patient toxicities to successfully progress your ADC into and through the clinic AbbVie, Shasqi, and SOTIO Biotech
- Achieving ADC Clinical Differentiation: Strengthen your clinical strategy by leveraging technologies for optimal patient selection, smartly select the correct combination partners, and demonstrate differentiation in crowded clinical landscapes with Daiichi Sankyo, GSK, and Pfizer
- Reducing ADC Production Costs: Streamline process development with site-specific conjugation, scale-up to late-stage manufacturing with confidence, and ensure sustainable, cost-efficient development to make ADCs more accessible to patients with BeOne Medicines, Exelixis and Merck & Co.
Whatever your experience in the field, World ADC San Diego has you covered!
The Antibody Society members save 10% off the conference registration. Contact membership@antibodysociety.org or visit the ‘Members Only’ section on the TAbS website to find the discount code.
